ro 31-8220 has been researched along with pyrazolanthrone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Calvo, N; de Boland, AR; Gentili, C | 1 |
2 other study(ies) available for ro 31-8220 and pyrazolanthrone
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
Parathyroid hormone and the regulation of cell cycle in colon adenocarcinoma cells.
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Benzophenanthridines; Caco-2 Cells; Cell Cycle; Colonic Neoplasms; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; G1 Phase; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Parathyroid Hormone; Protein Kinase C; Protein Kinase Inhibitors; Signal Transduction | 2011 |